nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—CYP3A4—Pilocarpine—glaucoma	0.0665	0.166	CbGbCtD
Estramustine—ABCB1—Timolol—glaucoma	0.0637	0.159	CbGbCtD
Estramustine—ABCB1—Clonidine—glaucoma	0.0542	0.135	CbGbCtD
Estramustine—CYP3A4—Brinzolamide—glaucoma	0.0522	0.13	CbGbCtD
Estramustine—CYP3A4—Dorzolamide—glaucoma	0.0504	0.126	CbGbCtD
Estramustine—CYP3A4—Methazolamide—glaucoma	0.0449	0.112	CbGbCtD
Estramustine—CYP3A4—Acetazolamide—glaucoma	0.0359	0.0897	CbGbCtD
Estramustine—CYP3A4—Clonidine—glaucoma	0.0325	0.0811	CbGbCtD
Estramustine—MAP2—LKB1 signaling events—RPTOR—glaucoma	0.00925	0.0698	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00758	0.0572	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.00701	0.0529	CbGpPWpGaD
Estramustine—MAP2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.00666	0.0502	CbGpPWpGaD
Estramustine—MAP2—Melatonin metabolism and effects—EDN1—glaucoma	0.00539	0.0406	CbGpPWpGaD
Estramustine—MAP2—Melatonin metabolism and effects—APOE—glaucoma	0.00438	0.033	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.00384	0.029	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.00354	0.0267	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor beta network—C3—glaucoma	0.00308	0.0232	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00292	0.022	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00272	0.0205	CbGpPWpGaD
Estramustine—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00252	0.019	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00249	0.0187	CbGpPWpGaD
Estramustine—ESR1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.00246	0.0186	CbGpPWpGaD
Estramustine—ESR2—Ovarian Infertility Genes—CCND2—glaucoma	0.00223	0.0168	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00195	0.0147	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.00194	0.0146	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—RPTOR—glaucoma	0.0018	0.0136	CbGpPWpGaD
Estramustine—ESR1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.00164	0.0123	CbGpPWpGaD
Estramustine—Liver function test abnormal—Brinzolamide—glaucoma	0.00153	0.00331	CcSEcCtD
Estramustine—ESR2—Nuclear Receptors—NR3C1—glaucoma	0.00153	0.0115	CbGpPWpGaD
Estramustine—Estrone—CYP1B1—glaucoma	0.00153	0.423	CrCbGaD
Estramustine—Mood swings—Pilocarpine—glaucoma	0.00151	0.00326	CcSEcCtD
Estramustine—Liver function test abnormal—Pilocarpine—glaucoma	0.00147	0.00318	CcSEcCtD
Estramustine—Dry skin—Pilocarpine—glaucoma	0.00146	0.00315	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00145	0.0109	CbGpPWpGaD
Estramustine—Oedema—Carteolol—glaucoma	0.00144	0.00312	CcSEcCtD
Estramustine—Leukopenia—Methazolamide—glaucoma	0.00143	0.00309	CcSEcCtD
Estramustine—Chest pain—Levobunolol—glaucoma	0.00142	0.00307	CcSEcCtD
Estramustine—Cardiac failure congestive—Clonidine—glaucoma	0.0014	0.00303	CcSEcCtD
Estramustine—Cramps of lower extremities—Betaxolol—glaucoma	0.0014	0.00303	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00139	0.0105	CbGpPWpGaD
Estramustine—Thrombocytopenia—Diclofenamide—glaucoma	0.00139	0.003	CcSEcCtD
Estramustine—Dyspnoea—Metipranolol—glaucoma	0.00139	0.003	CcSEcCtD
Estramustine—Abdominal discomfort—Brinzolamide—glaucoma	0.00138	0.00297	CcSEcCtD
Estramustine—Libido decreased—Clonidine—glaucoma	0.00137	0.00296	CcSEcCtD
Estramustine—Depression—Brimonidine—glaucoma	0.00136	0.00293	CcSEcCtD
Estramustine—Lacrimation increased—Timolol—glaucoma	0.00135	0.00292	CcSEcCtD
Estramustine—Anorexia—Diclofenamide—glaucoma	0.00135	0.00292	CcSEcCtD
Estramustine—Erectile dysfunction—Dorzolamide—glaucoma	0.00134	0.0029	CcSEcCtD
Estramustine—Thirst—Clonidine—glaucoma	0.00134	0.00289	CcSEcCtD
Estramustine—Erectile dysfunction—Brinzolamide—glaucoma	0.00132	0.00285	CcSEcCtD
Estramustine—Chest pain—Latanoprost—glaucoma	0.00132	0.00285	CcSEcCtD
Estramustine—Insomnia—Carteolol—glaucoma	0.00131	0.00282	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—TP53—glaucoma	0.0013	0.00983	CbGpPWpGaD
Estramustine—Lethargy—Clonidine—glaucoma	0.0013	0.0028	CcSEcCtD
Estramustine—Cerebrovascular accident—Clonidine—glaucoma	0.0013	0.0028	CcSEcCtD
Estramustine—Depression—Dorzolamide—glaucoma	0.0013	0.0028	CcSEcCtD
Estramustine—Depression—Travoprost—glaucoma	0.00129	0.00279	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—NGF—glaucoma	0.00129	0.00972	CbGpPWpGaD
Estramustine—Dyspnoea—Carteolol—glaucoma	0.00129	0.00278	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00128	0.00967	CbGpPWpGaD
Estramustine—Acute coronary syndrome—Dorzolamide—glaucoma	0.00128	0.00277	CcSEcCtD
Estramustine—Thrombophlebitis—Betaxolol—glaucoma	0.00128	0.00276	CcSEcCtD
Estramustine—Depression—Brinzolamide—glaucoma	0.00128	0.00275	CcSEcCtD
Estramustine—Myocardial infarction—Dorzolamide—glaucoma	0.00128	0.00275	CcSEcCtD
Estramustine—Oedema—Latanoprost—glaucoma	0.00127	0.00273	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Clonidine—glaucoma	0.00126	0.00273	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00125	0.00945	CbGpPWpGaD
Estramustine—Anorexia—Methazolamide—glaucoma	0.00125	0.00269	CcSEcCtD
Estramustine—Decreased appetite—Diclofenamide—glaucoma	0.00123	0.00266	CcSEcCtD
Estramustine—Eye pain—Betaxolol—glaucoma	0.00123	0.00265	CcSEcCtD
Estramustine—Dyspnoea—Levobunolol—glaucoma	0.00122	0.00263	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.00122	0.00916	CbGpPWpGaD
Estramustine—Acute coronary syndrome—Pilocarpine—glaucoma	0.00121	0.00261	CcSEcCtD
Estramustine—ESR2—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00121	0.00912	CbGpPWpGaD
Estramustine—Myocardial infarction—Pilocarpine—glaucoma	0.00121	0.0026	CcSEcCtD
Estramustine—Libido decreased—Betaxolol—glaucoma	0.0012	0.00258	CcSEcCtD
Estramustine—Tinnitus—Acetazolamide—glaucoma	0.00119	0.00256	CcSEcCtD
Estramustine—Flushing—Acetazolamide—glaucoma	0.00118	0.00255	CcSEcCtD
Estramustine—Liver function test abnormal—Clonidine—glaucoma	0.00118	0.00254	CcSEcCtD
Estramustine—Thirst—Betaxolol—glaucoma	0.00117	0.00251	CcSEcCtD
Estramustine—Estradiol—CYP1B1—glaucoma	0.00116	0.32	CrCbGaD
Estramustine—Decreased appetite—Methazolamide—glaucoma	0.00114	0.00245	CcSEcCtD
Estramustine—Flushing—Brimonidine—glaucoma	0.00114	0.00245	CcSEcCtD
Estramustine—Lethargy—Betaxolol—glaucoma	0.00113	0.00244	CcSEcCtD
Estramustine—Dyspnoea—Latanoprost—glaucoma	0.00113	0.00243	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Betaxolol—glaucoma	0.0011	0.00237	CcSEcCtD
Estramustine—Affect lability—Betaxolol—glaucoma	0.00109	0.00235	CcSEcCtD
Estramustine—Tinnitus—Dorzolamide—glaucoma	0.00109	0.00235	CcSEcCtD
Estramustine—Tinnitus—Travoprost—glaucoma	0.00108	0.00234	CcSEcCtD
Estramustine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00108	0.00812	CbGpPWpGaD
Estramustine—Tinnitus—Brinzolamide—glaucoma	0.00107	0.00231	CcSEcCtD
Estramustine—Chest pain—Apraclonidine—glaucoma	0.00106	0.00228	CcSEcCtD
Estramustine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00105	0.00793	CbGpPWpGaD
Estramustine—Mood swings—Betaxolol—glaucoma	0.00105	0.00227	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00105	0.0079	CbGpPWpGaD
Estramustine—Alopecia—Dorzolamide—glaucoma	0.00103	0.00223	CcSEcCtD
Estramustine—Tinnitus—Pilocarpine—glaucoma	0.00103	0.00222	CcSEcCtD
Estramustine—Flushing—Pilocarpine—glaucoma	0.00102	0.00221	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.00102	0.00772	CbGpPWpGaD
Estramustine—Chest pain—Bimatoprost—glaucoma	0.00102	0.00221	CcSEcCtD
Estramustine—Anxiety—Bimatoprost—glaucoma	0.00102	0.0022	CcSEcCtD
Estramustine—Alopecia—Brinzolamide—glaucoma	0.00101	0.00219	CcSEcCtD
Estramustine—Erectile dysfunction—Clonidine—glaucoma	0.00101	0.00219	CcSEcCtD
Estramustine—ESR2—Ovarian Infertility Genes—CDKN1B—glaucoma	0.00101	0.00764	CbGpPWpGaD
Estramustine—Oedema—Apraclonidine—glaucoma	0.00101	0.00218	CcSEcCtD
Estramustine—Pruritus—Diclofenamide—glaucoma	0.001	0.00217	CcSEcCtD
Estramustine—Eye pain—Timolol—glaucoma	0.001	0.00217	CcSEcCtD
Estramustine—Cardiac failure congestive—Timolol—glaucoma	0.000999	0.00216	CcSEcCtD
Estramustine—Leukopenia—Acetazolamide—glaucoma	0.000993	0.00214	CcSEcCtD
Estramustine—Flatulence—Brinzolamide—glaucoma	0.000985	0.00212	CcSEcCtD
Estramustine—Rash—Metipranolol—glaucoma	0.000983	0.00212	CcSEcCtD
Estramustine—Dermatitis—Metipranolol—glaucoma	0.000982	0.00212	CcSEcCtD
Estramustine—Depression—Clonidine—glaucoma	0.000979	0.00211	CcSEcCtD
Estramustine—Libido decreased—Timolol—glaucoma	0.000977	0.00211	CcSEcCtD
Estramustine—Headache—Metipranolol—glaucoma	0.000977	0.00211	CcSEcCtD
Estramustine—Alopecia—Pilocarpine—glaucoma	0.000975	0.0021	CcSEcCtD
Estramustine—Pruritus—Levobunolol—glaucoma	0.000966	0.00208	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000963	0.00726	CbGpPWpGaD
Estramustine—Muscle spasms—Brinzolamide—glaucoma	0.000961	0.00207	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.00096	0.00723	CbGpPWpGaD
Estramustine—Diarrhoea—Carbachol—glaucoma	0.000949	0.00205	CcSEcCtD
Estramustine—Flatulence—Pilocarpine—glaucoma	0.000947	0.00204	CcSEcCtD
Estramustine—Diarrhoea—Levobunolol—glaucoma	0.000934	0.00201	CcSEcCtD
Estramustine—Testosterone—CYP1B1—glaucoma	0.000928	0.257	CrCbGaD
Estramustine—Nausea—Metipranolol—glaucoma	0.000926	0.002	CcSEcCtD
Estramustine—Cerebrovascular accident—Timolol—glaucoma	0.000925	0.00199	CcSEcCtD
Estramustine—Muscle spasms—Pilocarpine—glaucoma	0.000924	0.00199	CcSEcCtD
Estramustine—Insomnia—Apraclonidine—glaucoma	0.000915	0.00197	CcSEcCtD
Estramustine—Chest pain—Brimonidine—glaucoma	0.000906	0.00196	CcSEcCtD
Estramustine—Headache—Carteolol—glaucoma	0.000905	0.00195	CcSEcCtD
Estramustine—Anxiety—Brimonidine—glaucoma	0.000903	0.00195	CcSEcCtD
Estramustine—Vomiting—Diclofenamide—glaucoma	0.000903	0.00195	CcSEcCtD
Estramustine—Dyspnoea—Apraclonidine—glaucoma	0.000902	0.00195	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Timolol—glaucoma	0.000899	0.00194	CcSEcCtD
Estramustine—Pruritus—Latanoprost—glaucoma	0.000896	0.00193	CcSEcCtD
Estramustine—Rash—Diclofenamide—glaucoma	0.000896	0.00193	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000896	0.00675	CbGpPWpGaD
Estramustine—Diarrhoea—Methazolamide—glaucoma	0.000895	0.00193	CcSEcCtD
Estramustine—Affect lability—Timolol—glaucoma	0.000892	0.00192	CcSEcCtD
Estramustine—Headache—Diclofenamide—glaucoma	0.00089	0.00192	CcSEcCtD
Estramustine—Insomnia—Bimatoprost—glaucoma	0.000888	0.00191	CcSEcCtD
Estramustine—Thrombocytopenia—Acetazolamide—glaucoma	0.000886	0.00191	CcSEcCtD
Estramustine—Erectile dysfunction—Betaxolol—glaucoma	0.000883	0.0019	CcSEcCtD
Estramustine—Vomiting—Carbachol—glaucoma	0.000881	0.0019	CcSEcCtD
Estramustine—Dyspnoea—Bimatoprost—glaucoma	0.000875	0.00189	CcSEcCtD
Estramustine—Rash—Carbachol—glaucoma	0.000874	0.00189	CcSEcCtD
Estramustine—Dermatitis—Carbachol—glaucoma	0.000873	0.00188	CcSEcCtD
Estramustine—Oedema—Brimonidine—glaucoma	0.000869	0.00187	CcSEcCtD
Estramustine—Headache—Carbachol—glaucoma	0.000869	0.00187	CcSEcCtD
Estramustine—Chest pain—Dorzolamide—glaucoma	0.000866	0.00187	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—TGFB2—glaucoma	0.000863	0.00651	CbGpPWpGaD
Estramustine—Anxiety—Dorzolamide—glaucoma	0.000863	0.00186	CcSEcCtD
Estramustine—Chest pain—Travoprost—glaucoma	0.000862	0.00186	CcSEcCtD
Estramustine—Cardiac arrest—Timolol—glaucoma	0.000862	0.00186	CcSEcCtD
Estramustine—Leukopenia—Pilocarpine—glaucoma	0.00086	0.00186	CcSEcCtD
Estramustine—Anxiety—Travoprost—glaucoma	0.000859	0.00185	CcSEcCtD
Estramustine—Mood swings—Timolol—glaucoma	0.000858	0.00185	CcSEcCtD
Estramustine—Nausea—Carteolol—glaucoma	0.000858	0.00185	CcSEcCtD
Estramustine—Headache—Levobunolol—glaucoma	0.000855	0.00184	CcSEcCtD
Estramustine—Depression—Betaxolol—glaucoma	0.000852	0.00184	CcSEcCtD
Estramustine—Chest pain—Brinzolamide—glaucoma	0.000851	0.00184	CcSEcCtD
Estramustine—Nausea—Diclofenamide—glaucoma	0.000844	0.00182	CcSEcCtD
Estramustine—Acute coronary syndrome—Betaxolol—glaucoma	0.000843	0.00182	CcSEcCtD
Estramustine—Myocardial infarction—Betaxolol—glaucoma	0.000838	0.00181	CcSEcCtD
Estramustine—Liver function test abnormal—Timolol—glaucoma	0.000837	0.0018	CcSEcCtD
Estramustine—Vomiting—Methazolamide—glaucoma	0.000832	0.00179	CcSEcCtD
Estramustine—Oedema—Dorzolamide—glaucoma	0.00083	0.00179	CcSEcCtD
Estramustine—ESR1—FOXA1 transcription factor network—SOD1—glaucoma	0.000827	0.00624	CbGpPWpGaD
Estramustine—Oedema—Travoprost—glaucoma	0.000826	0.00178	CcSEcCtD
Estramustine—Rash—Methazolamide—glaucoma	0.000825	0.00178	CcSEcCtD
Estramustine—Dermatitis—Methazolamide—glaucoma	0.000824	0.00178	CcSEcCtD
Estramustine—Nausea—Carbachol—glaucoma	0.000823	0.00178	CcSEcCtD
Estramustine—Tinnitus—Clonidine—glaucoma	0.000822	0.00177	CcSEcCtD
Estramustine—Headache—Methazolamide—glaucoma	0.000819	0.00177	CcSEcCtD
Estramustine—Chest pain—Pilocarpine—glaucoma	0.000818	0.00176	CcSEcCtD
Estramustine—Anxiety—Pilocarpine—glaucoma	0.000815	0.00176	CcSEcCtD
Estramustine—Nausea—Levobunolol—glaucoma	0.000811	0.00175	CcSEcCtD
Estramustine—Rash—Latanoprost—glaucoma	0.000798	0.00172	CcSEcCtD
Estramustine—Dermatitis—Latanoprost—glaucoma	0.000798	0.00172	CcSEcCtD
Estramustine—Headache—Latanoprost—glaucoma	0.000793	0.00171	CcSEcCtD
Estramustine—Anorexia—Dorzolamide—glaucoma	0.000791	0.00171	CcSEcCtD
Estramustine—Decreased appetite—Acetazolamide—glaucoma	0.000787	0.0017	CcSEcCtD
Estramustine—Insomnia—Brimonidine—glaucoma	0.000786	0.0017	CcSEcCtD
Estramustine—Oedema—Pilocarpine—glaucoma	0.000784	0.00169	CcSEcCtD
Estramustine—Alopecia—Clonidine—glaucoma	0.000779	0.00168	CcSEcCtD
Estramustine—Nausea—Methazolamide—glaucoma	0.000777	0.00168	CcSEcCtD
Estramustine—Dyspnoea—Brimonidine—glaucoma	0.000775	0.00167	CcSEcCtD
Estramustine—ESR1—Signaling events mediated by HDAC Class II—NR3C1—glaucoma	0.000772	0.00582	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptors—NR3C1—glaucoma	0.000772	0.00582	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.00077	0.0058	CbGpPWpGaD
Estramustine—Thrombocytopenia—Pilocarpine—glaucoma	0.000768	0.00166	CcSEcCtD
Estramustine—Insomnia—Dorzolamide—glaucoma	0.000751	0.00162	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00075	0.00565	CbGpPWpGaD
Estramustine—Anorexia—Pilocarpine—glaucoma	0.000747	0.00161	CcSEcCtD
Estramustine—Dyspnoea—Dorzolamide—glaucoma	0.00074	0.0016	CcSEcCtD
Estramustine—Insomnia—Brinzolamide—glaucoma	0.000738	0.00159	CcSEcCtD
Estramustine—Muscle spasms—Clonidine—glaucoma	0.000738	0.00159	CcSEcCtD
Estramustine—Dyspnoea—Travoprost—glaucoma	0.000737	0.00159	CcSEcCtD
Estramustine—Dyspnoea—Brinzolamide—glaucoma	0.000727	0.00157	CcSEcCtD
Estramustine—Decreased appetite—Dorzolamide—glaucoma	0.000721	0.00156	CcSEcCtD
Estramustine—Erectile dysfunction—Timolol—glaucoma	0.000721	0.00156	CcSEcCtD
Estramustine—Pruritus—Apraclonidine—glaucoma	0.000716	0.00154	CcSEcCtD
Estramustine—Tinnitus—Betaxolol—glaucoma	0.000715	0.00154	CcSEcCtD
Estramustine—Flushing—Betaxolol—glaucoma	0.000712	0.00154	CcSEcCtD
Estramustine—Insomnia—Pilocarpine—glaucoma	0.000709	0.00153	CcSEcCtD
Estramustine—Decreased appetite—Brinzolamide—glaucoma	0.000709	0.00153	CcSEcCtD
Estramustine—Dyspnoea—Pilocarpine—glaucoma	0.000699	0.00151	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000698	0.00526	CbGpPWpGaD
Estramustine—Depression—Timolol—glaucoma	0.000696	0.0015	CcSEcCtD
Estramustine—Pruritus—Bimatoprost—glaucoma	0.000694	0.0015	CcSEcCtD
Estramustine—Diarrhoea—Apraclonidine—glaucoma	0.000692	0.00149	CcSEcCtD
Estramustine—Decreased appetite—Pilocarpine—glaucoma	0.000682	0.00147	CcSEcCtD
Estramustine—Alopecia—Betaxolol—glaucoma	0.000678	0.00146	CcSEcCtD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000663	0.005	CbGpPWpGaD
Estramustine—Chest pain—Clonidine—glaucoma	0.000653	0.00141	CcSEcCtD
Estramustine—Anxiety—Clonidine—glaucoma	0.000651	0.0014	CcSEcCtD
Estramustine—Vomiting—Apraclonidine—glaucoma	0.000644	0.00139	CcSEcCtD
Estramustine—Muscle spasms—Betaxolol—glaucoma	0.000642	0.00139	CcSEcCtD
Estramustine—Dermatitis—Apraclonidine—glaucoma	0.000638	0.00138	CcSEcCtD
Estramustine—Headache—Apraclonidine—glaucoma	0.000634	0.00137	CcSEcCtD
Estramustine—Oedema—Clonidine—glaucoma	0.000626	0.00135	CcSEcCtD
Estramustine—Diarrhoea—Acetazolamide—glaucoma	0.000619	0.00134	CcSEcCtD
Estramustine—Rash—Bimatoprost—glaucoma	0.000619	0.00133	CcSEcCtD
Estramustine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000618	0.00466	CbGpPWpGaD
Estramustine—Dermatitis—Bimatoprost—glaucoma	0.000618	0.00133	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000616	0.00464	CbGpPWpGaD
Estramustine—Pruritus—Brimonidine—glaucoma	0.000615	0.00133	CcSEcCtD
Estramustine—Headache—Bimatoprost—glaucoma	0.000615	0.00133	CcSEcCtD
Estramustine—Thrombocytopenia—Clonidine—glaucoma	0.000613	0.00132	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.000613	0.00462	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00061	0.0046	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000603	0.00455	CbGpPWpGaD
Estramustine—Nausea—Apraclonidine—glaucoma	0.000601	0.0013	CcSEcCtD
Estramustine—Anorexia—Clonidine—glaucoma	0.000597	0.00129	CcSEcCtD
Estramustine—Pruritus—Dorzolamide—glaucoma	0.000587	0.00127	CcSEcCtD
Estramustine—Pruritus—Travoprost—glaucoma	0.000585	0.00126	CcSEcCtD
Estramustine—Tinnitus—Timolol—glaucoma	0.000584	0.00126	CcSEcCtD
Estramustine—Nausea—Bimatoprost—glaucoma	0.000583	0.00126	CcSEcCtD
Estramustine—Pruritus—Brinzolamide—glaucoma	0.000577	0.00125	CcSEcCtD
Estramustine—Vomiting—Acetazolamide—glaucoma	0.000576	0.00124	CcSEcCtD
Estramustine—Chest pain—Betaxolol—glaucoma	0.000569	0.00123	CcSEcCtD
Estramustine—Diarrhoea—Dorzolamide—glaucoma	0.000568	0.00122	CcSEcCtD
Estramustine—Headache—Acetazolamide—glaucoma	0.000567	0.00122	CcSEcCtD
Estramustine—Anxiety—Betaxolol—glaucoma	0.000567	0.00122	CcSEcCtD
Estramustine—Insomnia—Clonidine—glaucoma	0.000566	0.00122	CcSEcCtD
Estramustine—Diarrhoea—Travoprost—glaucoma	0.000565	0.00122	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00056	0.00422	CbGpPWpGaD
Estramustine—Dyspnoea—Clonidine—glaucoma	0.000558	0.0012	CcSEcCtD
Estramustine—Diarrhoea—Brinzolamide—glaucoma	0.000558	0.0012	CcSEcCtD
Estramustine—Pruritus—Pilocarpine—glaucoma	0.000555	0.0012	CcSEcCtD
Estramustine—Alopecia—Timolol—glaucoma	0.000554	0.00119	CcSEcCtD
Estramustine—Rash—Brimonidine—glaucoma	0.000548	0.00118	CcSEcCtD
Estramustine—Dermatitis—Brimonidine—glaucoma	0.000547	0.00118	CcSEcCtD
Estramustine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000547	0.00412	CbGpPWpGaD
Estramustine—Oedema—Betaxolol—glaucoma	0.000545	0.00118	CcSEcCtD
Estramustine—Headache—Brimonidine—glaucoma	0.000544	0.00117	CcSEcCtD
Estramustine—Decreased appetite—Clonidine—glaucoma	0.000544	0.00117	CcSEcCtD
Estramustine—Nausea—Acetazolamide—glaucoma	0.000538	0.00116	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000538	0.00405	CbGpPWpGaD
Estramustine—Diarrhoea—Pilocarpine—glaucoma	0.000536	0.00116	CcSEcCtD
Estramustine—Thrombocytopenia—Betaxolol—glaucoma	0.000534	0.00115	CcSEcCtD
Estramustine—Vomiting—Dorzolamide—glaucoma	0.000528	0.00114	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—TNF—glaucoma	0.000528	0.00398	CbGpPWpGaD
Estramustine—Rash—Dorzolamide—glaucoma	0.000523	0.00113	CcSEcCtD
Estramustine—Dermatitis—Dorzolamide—glaucoma	0.000523	0.00113	CcSEcCtD
Estramustine—Rash—Travoprost—glaucoma	0.000521	0.00112	CcSEcCtD
Estramustine—Dermatitis—Travoprost—glaucoma	0.00052	0.00112	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00052	0.00392	CbGpPWpGaD
Estramustine—Headache—Dorzolamide—glaucoma	0.00052	0.00112	CcSEcCtD
Estramustine—Anorexia—Betaxolol—glaucoma	0.00052	0.00112	CcSEcCtD
Estramustine—Vomiting—Brinzolamide—glaucoma	0.000519	0.00112	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—EDN1—glaucoma	0.000518	0.0039	CbGpPWpGaD
Estramustine—Headache—Travoprost—glaucoma	0.000518	0.00112	CcSEcCtD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.000516	0.00389	CbGpPWpGaD
Estramustine—Nausea—Brimonidine—glaucoma	0.000516	0.00111	CcSEcCtD
Estramustine—Rash—Brinzolamide—glaucoma	0.000514	0.00111	CcSEcCtD
Estramustine—Dermatitis—Brinzolamide—glaucoma	0.000514	0.00111	CcSEcCtD
Estramustine—Headache—Brinzolamide—glaucoma	0.000511	0.0011	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—MMP2—glaucoma	0.000507	0.00382	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.000502	0.00379	CbGpPWpGaD
Estramustine—Vomiting—Pilocarpine—glaucoma	0.000499	0.00108	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—NGF—glaucoma	0.000497	0.00375	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000496	0.00374	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000495	0.00373	CbGpPWpGaD
Estramustine—Rash—Pilocarpine—glaucoma	0.000494	0.00107	CcSEcCtD
Estramustine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000494	0.00373	CbGpPWpGaD
Estramustine—Dermatitis—Pilocarpine—glaucoma	0.000494	0.00107	CcSEcCtD
Estramustine—Insomnia—Betaxolol—glaucoma	0.000493	0.00106	CcSEcCtD
Estramustine—Nausea—Dorzolamide—glaucoma	0.000493	0.00106	CcSEcCtD
Estramustine—Headache—Pilocarpine—glaucoma	0.000491	0.00106	CcSEcCtD
Estramustine—Nausea—Travoprost—glaucoma	0.000491	0.00106	CcSEcCtD
Estramustine—Dyspnoea—Betaxolol—glaucoma	0.000486	0.00105	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000486	0.00366	CbGpPWpGaD
Estramustine—Nausea—Brinzolamide—glaucoma	0.000485	0.00105	CcSEcCtD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.000484	0.00365	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.00048	0.00362	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000479	0.00361	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000476	0.00359	CbGpPWpGaD
Estramustine—Decreased appetite—Betaxolol—glaucoma	0.000474	0.00102	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—NR3C1—glaucoma	0.000473	0.00357	CbGpPWpGaD
Estramustine—Nausea—Pilocarpine—glaucoma	0.000466	0.001	CcSEcCtD
Estramustine—Chest pain—Timolol—glaucoma	0.000465	0.001	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—CDKN2A—glaucoma	0.000464	0.0035	CbGpPWpGaD
Estramustine—Anxiety—Timolol—glaucoma	0.000463	0.000999	CcSEcCtD
Estramustine—Oedema—Timolol—glaucoma	0.000445	0.000961	CcSEcCtD
Estramustine—Pruritus—Clonidine—glaucoma	0.000443	0.000956	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—MMP1—glaucoma	0.000435	0.00328	CbGpPWpGaD
Estramustine—Diarrhoea—Clonidine—glaucoma	0.000428	0.000924	CcSEcCtD
Estramustine—Anorexia—Timolol—glaucoma	0.000425	0.000916	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000421	0.00318	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—BCL2L1—glaucoma	0.00041	0.00309	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000408	0.00307	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000404	0.00304	CbGpPWpGaD
Estramustine—Insomnia—Timolol—glaucoma	0.000403	0.000869	CcSEcCtD
Estramustine—Vomiting—Clonidine—glaucoma	0.000398	0.000859	CcSEcCtD
Estramustine—Dyspnoea—Timolol—glaucoma	0.000397	0.000856	CcSEcCtD
Estramustine—ESR1—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000396	0.00299	CbGpPWpGaD
Estramustine—Rash—Clonidine—glaucoma	0.000395	0.000852	CcSEcCtD
Estramustine—Dermatitis—Clonidine—glaucoma	0.000394	0.000851	CcSEcCtD
Estramustine—Headache—Clonidine—glaucoma	0.000392	0.000846	CcSEcCtD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000388	0.00293	CbGpPWpGaD
Estramustine—Decreased appetite—Timolol—glaucoma	0.000387	0.000835	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—MMP2—glaucoma	0.000386	0.00291	CbGpPWpGaD
Estramustine—Pruritus—Betaxolol—glaucoma	0.000386	0.000832	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000382	0.00288	CbGpPWpGaD
Estramustine—Diarrhoea—Betaxolol—glaucoma	0.000373	0.000805	CcSEcCtD
Estramustine—Nausea—Clonidine—glaucoma	0.000372	0.000802	CcSEcCtD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000372	0.0028	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—BAD—glaucoma	0.000371	0.0028	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000352	0.00265	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000349	0.00263	CbGpPWpGaD
Estramustine—Vomiting—Betaxolol—glaucoma	0.000347	0.000748	CcSEcCtD
Estramustine—Rash—Betaxolol—glaucoma	0.000344	0.000741	CcSEcCtD
Estramustine—Dermatitis—Betaxolol—glaucoma	0.000343	0.000741	CcSEcCtD
Estramustine—Headache—Betaxolol—glaucoma	0.000342	0.000737	CcSEcCtD
Estramustine—Nausea—Betaxolol—glaucoma	0.000324	0.000698	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000318	0.0024	CbGpPWpGaD
Estramustine—Pruritus—Timolol—glaucoma	0.000315	0.00068	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000309	0.00233	CbGpPWpGaD
Estramustine—Diarrhoea—Timolol—glaucoma	0.000305	0.000657	CcSEcCtD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000299	0.00225	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—NOS3—glaucoma	0.000298	0.00225	CbGpPWpGaD
Estramustine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000292	0.0022	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000287	0.00216	CbGpPWpGaD
Estramustine—Vomiting—Timolol—glaucoma	0.000283	0.000611	CcSEcCtD
Estramustine—Rash—Timolol—glaucoma	0.000281	0.000606	CcSEcCtD
Estramustine—Dermatitis—Timolol—glaucoma	0.000281	0.000605	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	0.00028	0.00211	CbGpPWpGaD
Estramustine—Headache—Timolol—glaucoma	0.000279	0.000602	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000273	0.00206	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000272	0.00205	CbGpPWpGaD
Estramustine—Nausea—Timolol—glaucoma	0.000265	0.000571	CcSEcCtD
Estramustine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000263	0.00199	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000262	0.00198	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000256	0.00193	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—TP53—glaucoma	0.000254	0.00191	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.000253	0.00191	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000247	0.00186	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000243	0.00183	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000242	0.00182	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.00024	0.00181	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—CDKN2B—glaucoma	0.000238	0.00179	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000237	0.00179	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000236	0.00178	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000235	0.00177	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000233	0.00176	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—FAS—glaucoma	0.00022	0.00166	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—C3—glaucoma	0.000217	0.00164	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000212	0.0016	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—BAD—glaucoma	0.000211	0.00159	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NR3C1—glaucoma	0.000209	0.00158	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000205	0.00155	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—TNF—glaucoma	0.000203	0.00153	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000202	0.00152	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000192	0.00145	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000191	0.00144	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000186	0.0014	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000178	0.00134	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000176	0.00132	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LRP12—glaucoma	0.000174	0.00131	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000173	0.0013	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—glaucoma	0.000172	0.00129	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000153	0.00115	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	0.000147	0.00111	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA5A—glaucoma	0.000145	0.00109	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NARFL—glaucoma	0.000145	0.00109	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000139	0.00105	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000129	0.000974	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000128	0.000964	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000128	0.000962	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000127	0.000958	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000126	0.00095	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000123	0.000926	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000122	0.000923	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—OPN4—glaucoma	0.00012	0.000908	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	0.00012	0.000905	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000119	0.000895	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—CDKN2B—glaucoma	0.000115	0.000864	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HEYL—glaucoma	0.000112	0.000844	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—glaucoma	0.000109	0.000823	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000109	0.00082	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTGFR—glaucoma	0.000108	0.000818	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	0.000105	0.000794	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000102	0.000767	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	0.000102	0.000766	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NR3C1—glaucoma	0.000101	0.000758	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	0.0001	0.000756	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TNF—glaucoma	9.35e-05	0.000705	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	9.3e-05	0.000701	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	9.28e-05	0.0007	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA5A—glaucoma	8.94e-05	0.000674	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NARFL—glaucoma	8.94e-05	0.000674	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.72e-05	0.000658	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.69e-05	0.000655	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RPTOR—glaucoma	8.49e-05	0.00064	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NCK2—glaucoma	8.22e-05	0.00062	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTM1—glaucoma	8.13e-05	0.000613	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	8.01e-05	0.000604	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.69e-05	0.00058	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA1—glaucoma	7.09e-05	0.000534	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HDAC9—glaucoma	6.99e-05	0.000527	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CTSA—glaucoma	6.86e-05	0.000517	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.84e-05	0.000515	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA2—glaucoma	6.48e-05	0.000489	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.48e-05	0.000488	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—CDKN2B—glaucoma	5.78e-05	0.000436	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SMO—glaucoma	5.47e-05	0.000412	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.39e-05	0.000406	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NR3C1—glaucoma	5.07e-05	0.000382	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NTRK2—glaucoma	5e-05	0.000377	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.62e-05	0.000348	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TXN—glaucoma	4.57e-05	0.000344	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA1—glaucoma	4.37e-05	0.000329	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NGFR—glaucoma	4.29e-05	0.000324	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CTSA—glaucoma	4.23e-05	0.000319	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NTRK1—glaucoma	4.08e-05	0.000307	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.07e-05	0.000307	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA2—glaucoma	3.99e-05	0.000301	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN2B—glaucoma	3.76e-05	0.000283	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EDN1—glaucoma	3.61e-05	0.000272	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTT1—glaucoma	3.54e-05	0.000267	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NGF—glaucoma	3.31e-05	0.00025	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—C3—glaucoma	3.15e-05	0.000237	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—APOE—glaucoma	2.93e-05	0.000221	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CAV1—glaucoma	2.91e-05	0.000219	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ABCA1—glaucoma	2.82e-05	0.000213	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP1B1—glaucoma	2.82e-05	0.000213	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TXN—glaucoma	2.81e-05	0.000212	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FN1—glaucoma	2.77e-05	0.000208	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BAD—glaucoma	2.73e-05	0.000206	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTM1—glaucoma	2.26e-05	0.00017	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOS3—glaucoma	2.2e-05	0.000166	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTT1—glaucoma	2.18e-05	0.000164	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MTHFR—glaucoma	1.99e-05	0.00015	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN1B—glaucoma	1.9e-05	0.000143	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—APOE—glaucoma	1.86e-05	0.00014	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CAV1—glaucoma	1.84e-05	0.000139	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP9—glaucoma	1.76e-05	0.000133	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ABCA1—glaucoma	1.74e-05	0.000131	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP1B1—glaucoma	1.74e-05	0.000131	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—glaucoma	1.58e-05	0.000119	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NOS3—glaucoma	1.39e-05	0.000105	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTM1—glaucoma	1.39e-05	0.000105	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—glaucoma	1.27e-05	9.59e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MTHFR—glaucoma	1.23e-05	9.26e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—glaucoma	1.2e-05	9.02e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—APOE—glaucoma	1.14e-05	8.62e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CAV1—glaucoma	1.13e-05	8.54e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NOS3—glaucoma	8.57e-06	6.46e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—glaucoma	7.83e-06	5.91e-05	CbGpPWpGaD
